If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2010 Ph.D., National Cheng-Kung University, Taiwan
  • 2004 M.S., Chang-Gung University, Taiwan
  • 2002 B.S., Kaohsiung Medical University, Taiwan

Experience

  • 2017- Associate Professor, The Ph.D. Program for Neural Regenerative Medicine, Taipei Medical University
  • 2013-2017 Assistant Professor,The Ph.D. Program for Neural Regenerative Medicine, Taipei Medical University
  • 2011 Postdoctoral Fellow, National Institute on Drug Abuse, NIH, U.S.A.
  • 2010 Postdoctoral Fellow, National Cheng-Kung University, Tainan, Taiwan
  • 2009 Visiting Scholar, National Institute on Drug Abuse, NIH, , U.S.A
  • 2004 Research Assistant, Chang-Gung University, Taiwan

     

Awards

  • 2013 National Institutes of Health, Fellows Award for Research Excellence (FARE) 2013 winner
  • 2010 National Cheng Kung University, Excellent Research Award
  • 2009 The 17th International Symposium on Recent Advances in Cellular and Molecula Biology, Dr. Chien-Tien Hsu’ Award for Outstanding Dissertation
  • 2008 National Cheng Kung University, Excellent Research Award

Research Interests

  • Neuroprotection
  • Brain cancer stem cell
  • Drug addiction

URL

Fingerprint Dive into the research topics where Jian-Ying Chuang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

腦創傷後的神經再生研究(1/5)

Chuang, J.

2/1/201/31/21

Project: A - Government Institutionb - Ministry of Science and Technology

“愛憶欣-伏立諾他”聯合藥物MPT0G604對惡性腦瘤幹細胞的抗增生作用

Chuang, J.

3/1/192/1/20

Project: C - Project of Alliancem - Yuan's General Hospital

轉錄因子Sp1在癌症形成之基礎及轉譯研究-研究Sp1在化療藥物抗性的作用(3/3)

Chuang, J.

8/1/1810/1/19

Project: A - Government Institutionb - Ministry of Science and Technology

轉錄因子Sp1在癌症形成之基礎及轉譯研究-研究Sp1在化療藥物抗性的作用(3/3)(相對補助)

Chuang, J.

8/1/1812/31/19

Project: A - Government Institutionf - Other (Funded by Government)

Research Output

  • 997 Citations
  • 18 h-Index
  • 54 Article
  • 1 Conference contribution

AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis

Chen, T. C., Chuang, J. Y., Ko, C. Y., Kao, T. J., Yang, P. Y., Yu, C. H., Liu, M. S., Hu, S. L., Tsai, Y. T., Chan, H., Chang, W. C. & Hsu, T. I., Feb 1 2020, In : Redox Biology. 30, p. 101413 101413.

Research output: Contribution to journalArticle

Open Access
  • 1 Citation (Scopus)
    Open Access
  • BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine

    Chao, P. K., Chang, H. F., Chang, W. T., Yeh, T. K., Ou, L. C., Chuang, J. Y., Tsu-An Hsu, J., Tao, P. L., Loh, H. H., Shih, C., Ueng, S. H. & Yeh, S. H., Jan 1 2019, In : Neuropharmacology. 107678.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)
    Open Access
  • 2 Citations (Scopus)

    Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice

    Chao, P. K., Chang, H. F., Ou, L. C., Chuang, J. Y., Lee, P. T., Chang, W. T., Chen, S. C., Ueng, S. H., Hsu, J. T. A., Tao, P. L., Law, P. Y., Loh, H. H. & Yeh, S. H., Dec 1 2019, In : Scientific Reports. 9, 1, 2405.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)